Skip to Content

Updated Real-World Data Confirm the Effectiveness of Avelumab in First-Line Maintenance Treatment of Advanced Urothelial Carcinoma

Philippe Barthélémy discusses in this MEDtalk from ESMO 2024 the updated results from the AVENANCE trial. They confirm the effectiveness of avelumab first line maintenance in a real-world population.

Philippe Barthélémy

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top